Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
life sciences
2
×
national blog main
new york blog main
2
×
10x genomics
astellas pharma
becton dickinson
boehringer ingelheim
cancer
cancer diagnostics
clinical trials
deals
diagnostic device
eli lilly
empagliflozin
europe
europe blog main
europe top stories
fda
idiopathic pulmonary fibrosis (ipf)
indiana blog main
indiana top stories
lung cancer
lymphoma
medical device
merck
nanostring
new york top stories
raleigh-durham blog main
san diego blog main
san francisco
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
slgt2 inhibitor
type 1 diabetes
type 2 diabetes
veracyte
What
expand
2
×
adding
aims
approval
bid
boehringer
company
deal
decisions
diabetes
diagnostic
diagnostics
drug
eli
fallen
fda
fold
help
ingelheim
lilly
make
marketed
medicine’s
nanostring
patients
physicians
reach
rejects
short
technology
tests
treatment
type
veracyte
Language
unset
Current search:
expand
×
biotech
×
" life sciences "
×
" new york blog main "
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
